Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100737914 | 10073791 | 4 | F | 20121124 | 20160803 | 20140411 | 20160812 | EXP | JP-GILEAD-2014-0098949 | GILEAD | 66.00 | YR | E | F | Y | 47.00000 | KG | 20160812 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100737914 | 10073791 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Oral | 5 MG, QD | 32 | MG | 22081 | 5 | MG | TABLET | QD | ||||
| 100737914 | 10073791 | 2 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Oral | 7.5 MG, QD | 32 | MG | 22081 | 7.5 | MG | TABLET | QD | ||||
| 100737914 | 10073791 | 3 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Oral | 5 MG, QD | 32 | MG | 22081 | 5 | MG | TABLET | QD | ||||
| 100737914 | 10073791 | 4 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Oral | 2.5 MG, QD | 32 | MG | 22081 | 2.5 | MG | TABLET | QD | ||||
| 100737914 | 10073791 | 5 | SS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 100737914 | 10073791 | 6 | SS | REVATIO | SILDENAFIL CITRATE | 1 | 0 | TABLET | |||||||||||
| 100737914 | 10073791 | 7 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | UNK | Y | 0 | |||||||||
| 100737914 | 10073791 | 8 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | UNK | Y | 0 | |||||||||
| 100737914 | 10073791 | 9 | C | BERASUS | BERAPROST SODIUM | 1 | Oral | U | 0 | ||||||||||
| 100737914 | 10073791 | 10 | C | URSO | URSODIOL | 1 | Oral | U | 0 | ||||||||||
| 100737914 | 10073791 | 11 | C | JUVELA N | TOCOPHERYL NICOTINATE, D-.ALPHA. | 1 | Oral | U | 0 | CAPSULE | |||||||||
| 100737914 | 10073791 | 12 | C | JUVELA N | TOCOPHERYL NICOTINATE, D-.ALPHA. | 1 | Oral | UNK | U | 0 | CAPSULE | ||||||||
| 100737914 | 10073791 | 13 | C | JUVELA N | TOCOPHERYL NICOTINATE, D-.ALPHA. | 1 | Oral | UNK | U | 0 | CAPSULE | ||||||||
| 100737914 | 10073791 | 14 | C | JUVELA N | TOCOPHERYL NICOTINATE, D-.ALPHA. | 1 | Oral | UNK | U | 0 | CAPSULE | ||||||||
| 100737914 | 10073791 | 15 | C | LIPOVAS /00499301/ | FENOFIBRATE | 1 | Oral | U | 0 | ||||||||||
| 100737914 | 10073791 | 16 | C | Berasus LA | 2 | Oral | 0 | TABLET | |||||||||||
| 100737914 | 10073791 | 17 | C | URSO | URSODIOL | 1 | Oral | UNK | 0 | ORAL DRUG UNSPECIFIED FORM | |||||||||
| 100737914 | 10073791 | 18 | C | LIPOVAS (JAPAN) | 2 | Oral | UNK | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100737914 | 10073791 | 1 | Pulmonary arterial hypertension |
| 100737914 | 10073791 | 2 | Pulmonary arterial hypertension |
| 100737914 | 10073791 | 5 | Pulmonary arterial hypertension |
| 100737914 | 10073791 | 6 | Pulmonary arterial hypertension |
| 100737914 | 10073791 | 7 | Product used for unknown indication |
| 100737914 | 10073791 | 9 | Pulmonary arterial hypertension |
| 100737914 | 10073791 | 16 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100737914 | 10073791 | HO |
| 100737914 | 10073791 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100737914 | 10073791 | Breast cancer | |
| 100737914 | 10073791 | Hypokalaemia | |
| 100737914 | 10073791 | Off label use | |
| 100737914 | 10073791 | Pleural effusion | |
| 100737914 | 10073791 | Pneumonia | |
| 100737914 | 10073791 | Pulmonary oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100737914 | 10073791 | 1 | 20121114 | 0 | ||
| 100737914 | 10073791 | 2 | 20120919 | 20121113 | 0 | |
| 100737914 | 10073791 | 3 | 20120822 | 20120918 | 0 | |
| 100737914 | 10073791 | 4 | 20120808 | 20120821 | 0 | |
| 100737914 | 10073791 | 7 | 20121124 | 20121205 | 0 | |
| 100737914 | 10073791 | 8 | 20121206 | 0 |